Prophylactic progesterone to prevent preterm birth [3]

American Journal of Obstetrics and Gynecology

Volumn 190, Issue 6, 2004, Pages 1799-1800

  Tita, Alan Thevenet N ^a   O'Day, Mary P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROGESTERONE;

ALLERGY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; HORMONAL REGULATION; HORMONE SENSITIVITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PATIENT SELECTION; PREMATURE LABOR; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZATION; RISK ASSESSMENT; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS;

ADMINISTRATION, INTRAVAGINAL; FEMALE; GESTATIONAL AGE; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY OUTCOME; PREVALENCE; PRIMARY PREVENTION; PROBABILITY; PROGESTERONE; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 3442893859     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2003.12.046     Document Type: Letter

References (2)

1. Da Fonseca E.B., Bittar R.E., Carvalho M.H.B., Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double blind study. Am J Obstet Gynecol. 188:2003;419-424
2. Iams J.D. Supplemental progesterone to prevent preterm birth. (editorial) Am J Obstet Gynecol. 188:2003;303